by Rakovina Therapeutics | Oct 16, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, October 16, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV, FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that new preclinical...
by Rakovina Therapeutics | Oct 7, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, September 4, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that Executive...
by Rakovina Therapeutics | Sep 17, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, September 4, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that...
by Rakovina Therapeutics | Aug 29, 2025 | Uncategorized
All dollar amounts reflected in Canadian dollars unless otherwise stated. Vancouver, British Columbia, August 28, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing...
by Rakovina Therapeutics | Aug 29, 2025 | Uncategorized
DOWNLOAD VANCOUVER, BC, July 29, 2025 – Rakovina Therapeutics Inc. (TSXV: RKV) (FSE: 7JO0) (the “Company” or “Rakovina”), a biopharmaceutical company advancing cancer therapies through artificial intelligence (AI)-powered drug discovery, is...